FFO
JBIO

Fortitude Family Office’s Jade Biosciences JBIO Stock Holding History

Fortitude Family Office’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644 Buy
+29
New +$605 ﹤0.01% 1913
2024
Q3 		– Sell
-12
Closed -$691 – 1211
2024
Q2 		$691 Hold
12
– – ﹤0.01% 908
2024
Q1 		$12.3K Hold
12
– – 0.01% 354
2023
Q4 		$9.41K Buy
+12
New +$6.12K 0.01% 428

Other funds holding JBIO

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Fortitude Family Office's JBIO Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Jade Biosciences (JBIO) in Q2 2026: 29 shares worth $644. The stake represents ﹤0.01% of the portfolio and ranks #1913 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in JBIO as recently as Q2 2024.

Fortitude Family Office first reported a position in JBIO in Q4 2023 and has held it in 4 quarters since. The position peaked at $12.3K in Q1 2024. 17 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Fortitude Family Office held 29 shares of Jade Biosciences worth $644 as of Q2 2026.
  • Jade Biosciences was a new Fortitude Family Office position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1913 holding.
  • Fortitude Family Office first reported a position in Jade Biosciences in Q4 2023 and has held it in 4 quarters since.
  • Fortitude Family Office's Jade Biosciences position peaked at $12.3K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.